GLOBAL DIMENSIONAL COMPLEXITY OF THE EEG IN HEALTHY-VOLUNTEERS

被引:20
|
作者
MATOUSEK, M [1 ]
WACKERMANN, J [1 ]
PALUS, M [1 ]
BERANKOVA, A [1 ]
ALBRECHT, V [1 ]
DVORAK, I [1 ]
机构
[1] PRAGUE PSYCHIAT CTR,PRAGUE,CZECH REPUBLIC
关键词
EEG CORRELATION DIMENSION; EEG GLOBAL DIMENSIONAL COMPLEXITY; NONLINEAR METHODS; ALERTNESS LEVEL; AGE;
D O I
10.1159/000119171
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In contrast to the single-channel dimensional complexity, the global dimensional complexity is calculated from a multichannel EEG. The intention with the method is to measure the spatial distribution of information processing in the brain. The method seems to be of interest in psychopharmacological research, but the interpretation of the results in physiological terms is rather difficult. To get a more detailed information on the physiological significance of the EEG complexity measures, the influence of well-known physiological factors was studied in a group of 14 healthy subjects aged from 1.5 to 61 years. It was found that the correlation dimension was somewhat higher in older individuals, but the correlation with age was not statistically significant. However, the global correlation dimension was significantly lower during full alertness than during drowsiness. These results might reflect the changes in spatial structure of information processing, a high complexity suggesting a 'disorganisation' during drowsiness. As regards the age-dependent changes of the correlation dimension, the spatial 'flexibility' of information processing was also studied, using the differences between the 'alert' and 'drowsy' parts of the same EEG as indicator. It was found that the differences 'drowsy minus alert' were significantly related to age. A plausible interpretation seems to be that the spatial distribution of information processing is more changeable, or more flexible, in adults than in children.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 50 条
  • [21] IMMUNOMODULATION OF CIMETIDINE IN HEALTHY-VOLUNTEERS
    BROCKMEYER, NH
    KREUZFELDER, E
    BLUHM, C
    SHEN, G
    SCHEIERMANN, E
    KEINECKE, HO
    OHNHAUS, EE
    KLINISCHE WOCHENSCHRIFT, 1989, 67 (01): : 26 - 30
  • [22] PHARMACOKINETICS OF PINAZEPAM IN HEALTHY-VOLUNTEERS
    PACIFICI, GM
    PLACIDI, GF
    FORNARO, P
    GOMENI, R
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1983, 3 (05) : 331 - 337
  • [23] HEALTHY-VOLUNTEERS, RISK, AND RESEARCH
    POWELL, JR
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (10): : 776 - 777
  • [24] PHARMACOKINETICS OF PEFLOXACIN IN HEALTHY-VOLUNTEERS
    DISHOVSKI, H
    BARDAROV, V
    KOLEVA, G
    SHTEREV, A
    CHAVDAROVA, V
    IVANOV, T
    SHOPOVA, S
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 193 - 194
  • [25] CYCLOSPORINE KINETICS IN HEALTHY-VOLUNTEERS
    PTACHCINSKI, RJ
    VENKATARAMANAN, R
    BURCKART, GJ
    GRAY, JA
    VANTHIEL, DH
    SANGHVI, A
    ROSENTHAL, JT
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (03): : 243 - 248
  • [26] CIMETIDINE AND THE IMMUNORESPONSE IN HEALTHY-VOLUNTEERS
    BROCKMEYER, NH
    KREUZFELDER, E
    GUTTMANN, W
    MERTINS, L
    GOOS, M
    OHNHAUS, EE
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (06) : 757 - 761
  • [27] PHARMACOKINETICS OF CLOFAZIMINE IN HEALTHY-VOLUNTEERS
    SCHAADLANYI, Z
    DIETERLE, W
    DUBOIS, JP
    THEOBALD, W
    VISCHER, W
    INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 1987, 55 (01) : 9 - 15
  • [28] PHARMACOKINETICS OF IMIPENEM IN HEALTHY-VOLUNTEERS
    NORRBY, SR
    BJORNEGARD, B
    FERBER, F
    JONES, KH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 : 109 - 124
  • [29] BIOAVAILABILITY OF PLAFIBRIDE IN HEALTHY-VOLUNTEERS
    SANTANIELLO, E
    CONTI, F
    VILAGELIU, J
    BRUSEGHINI, L
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1981, 31-2 (10A): : 1850 - 1852
  • [30] ORAL ILOPROST IN HEALTHY-VOLUNTEERS
    HILDEBRAND, M
    PFEFFER, M
    MAHLER, M
    STAKS, T
    WINDTHANKE, F
    SCHUTT, A
    EICOSANOIDS, 1991, 4 (03) : 149 - 154